Otogenetics

Patients

  • GxVISION® Carrier Screening

  • EnVISION Non Invasive Prenatal® Screening

  • GxVISION® Hereditary Cancer Risk Assessment

Physicians

  • GxVISION® Carrier Screening

  • EnVISION Non-Invasive Prenatal® Screening

  • GxVISION® Hereditary Cancer Risk Assessment

  • GxVISION® Congenital Hearing Loss

Education Center

  • Physician Education Resources

  • Patient Education Resources

  • Patient Stories

Research & Partnerships

  • Research and Research Partners

  • GBinsight

Company

  • About Us

  • Contact Us

Whole-exome sequencing, without prior linkage, identifies a mutation in LAMB3 as a cause of dominant hypoplastic amelogenesis imperfecta

August 6, 2024

Poulter JA, El-Sayed W, Shore RC, Kirkham J, Inglehearn CF, and Mighell AJ. (2013) Whole-exome sequencing, without prior linkage, identifies a mutation in LAMB3 as a cause of dominant hypoplastic amelogenesis imperfecta. European Journal of Human Genetics. 22(1):132-5.

Otogenetics
  • 4553 Winters Chapel Rd., Suite 100 Atlanta, GA 30360
  • +1 (855)-686-4363
Contact Us

Patients

  • GxVISION® Carrier Screening

  • EnVISION Non Invasive Prenatal® Screening

  • GxVISION® Hereditary Cancer Risk Assessment

Physicians

  • GxVISION® Carrier Screening

  • EnVISION Non-Invasive Prenatal® Screening

  • GxVISION® Hereditary Cancer Risk Assessment

  • GxVISION® Congenital Hearing Loss

Education Center

  • Physician Education Resources

  • Patient Education Resources

  • Patient Stories

Research & Partnerships

  • Research and Research Partners

  • GBinsight

Company

  • About Us

  • Contact Us

  • Privacy Policy

© Otogenetics 2025 All Rights Reserved.